07:04 EDT Phathom Pharmaceuticals (PHAT) sees FY25 revenue $170M-$175M, consensus $170.4M
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Phathom Pharmaceuticals’ EoE Study: A Potential Game-Changer?
- Phathom Pharmaceuticals’ Vonoprazan Pregnancy Study: A Market Game Changer?
- Phathom Pharmaceuticals Publishes Phase 3 Trial Results
- Phathom Pharmaceuticals Appoints New Chief Financial Officer
- Phathom appoints Sanjeev Narula as chief financial, business officer